← back to search

Douglas M. Dahl

Harvard University · US
🔎 Find collaborators in Pulmonary and Respiratory Medicine · Surgery →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Pulmonary and Respiratory Medicine · Surgery
Research interest
Research interests include Prostate Cancer Diagnosis and Treatment, Prostate Cancer Treatment and Research, Bladder and Urothelial Cancer Treatments, and Renal cell carcinoma treatment.
h-index
38
citations
6,131
works
229
NIH funding
primary concept
Medicine
email

Recent publications

Comparing conventional, peripheral, and transition zone prostate-specific antigen densities for the detection of clinically significant prostate cancer
Clinical Radiology 2026cited by 0position: contributordoi
Pathologic Upgrading in Biopsy Grade Group 1, PI-RADS ≥ 3 Prostate Cancer: Factors Associated With Clinically Significant Disease on Radical Prostatectomy
Clinical Genitourinary Cancer 2026cited by 0position: contributordoi
Single-Cell and Spatial Transcriptomics Reveal a Tumor-Associated Macrophage Subpopulation that Mediates Prostate Cancer Progression and Metastasis
Molecular Cancer Research 2025cited by 17position: lastdoi
Single-Cell and Spatial Transcriptomics Reveal a Tumor-Associated Macrophage Subpopulation that Mediates Prostate Cancer Progression and Metastasis.
2025cited by 13position: contributordoi
Table S1 from Single-Cell and Spatial Transcriptomics Reveal a Tumor-Associated Macrophage Subpopulation that Mediates Prostate Cancer Progression and Metastasis
2025cited by 1position: contributordoi
Development, External Validation, and Deployment of RFAN-ML: A Machine Learning Model to Estimate Renal Function After Nephrectomy.
2025cited by 0position: contributordoi
Figure S6 from Single-Cell and Spatial Transcriptomics Reveal a Tumor-Associated Macrophage Subpopulation that Mediates Prostate Cancer Progression and Metastasis
2025cited by 0position: contributordoi
Table S5 from Single-Cell and Spatial Transcriptomics Reveal a Tumor-Associated Macrophage Subpopulation that Mediates Prostate Cancer Progression and Metastasis
2025cited by 0position: contributordoi
Data from Single-Cell and Spatial Transcriptomics Reveal a Tumor-Associated Macrophage Subpopulation that Mediates Prostate Cancer Progression and Metastasis
2025cited by 0position: contributordoi
Figure S5 from Single-Cell and Spatial Transcriptomics Reveal a Tumor-Associated Macrophage Subpopulation that Mediates Prostate Cancer Progression and Metastasis
2025cited by 0position: contributordoi
Table S2 from Single-Cell and Spatial Transcriptomics Reveal a Tumor-Associated Macrophage Subpopulation that Mediates Prostate Cancer Progression and Metastasis
2025cited by 0position: contributordoi
Figure S3 from Single-Cell and Spatial Transcriptomics Reveal a Tumor-Associated Macrophage Subpopulation that Mediates Prostate Cancer Progression and Metastasis
2025cited by 0position: contributordoi
Supplementary Figure Legends from Single-Cell and Spatial Transcriptomics Reveal a Tumor-Associated Macrophage Subpopulation that Mediates Prostate Cancer Progression and Metastasis
2025cited by 0position: contributordoi
Table S3 from Single-Cell and Spatial Transcriptomics Reveal a Tumor-Associated Macrophage Subpopulation that Mediates Prostate Cancer Progression and Metastasis
2025cited by 0position: contributordoi
Figure S4 from Single-Cell and Spatial Transcriptomics Reveal a Tumor-Associated Macrophage Subpopulation that Mediates Prostate Cancer Progression and Metastasis
2025cited by 0position: contributordoi
Figure S1 from Single-Cell and Spatial Transcriptomics Reveal a Tumor-Associated Macrophage Subpopulation that Mediates Prostate Cancer Progression and Metastasis
2025cited by 0position: contributordoi
Figure S2 from Single-Cell and Spatial Transcriptomics Reveal a Tumor-Associated Macrophage Subpopulation that Mediates Prostate Cancer Progression and Metastasis
2025cited by 0position: contributordoi
Table S4 from Single-Cell and Spatial Transcriptomics Reveal a Tumor-Associated Macrophage Subpopulation that Mediates Prostate Cancer Progression and Metastasis
2025cited by 0position: contributordoi
Single-cell analysis of immune and stroma cell remodeling in clear cell renal cell carcinoma primary tumors and bone metastatic lesions
Genome Medicine 2024cited by 51position: middledoi
Bladder-Preserving Trimodality Treatment for High-Grade T1 Bladder Cancer: Results From Phase II Protocol NRG Oncology/RTOG 0926
Journal of Clinical Oncology 2024cited by 23position: firstdoi
Bladder-Preserving Trimodality Treatment for High-Grade T1 Bladder Cancer: Results From Phase II Protocol NRG Oncology/RTOG 0926.
2024cited by 17position: contributordoi
Long-term Outcomes of Chemoradiation for Muscle-invasive Bladder Cancer in Noncystectomy Candidates. Final Results of NRG Oncology RTOG 0524—A Phase 1/2 Trial of Paclitaxel + Trastuzumab with Daily Radiation or Paclitaxel Alone with Daily Irradiation
European Urology Oncology 2024cited by 11position: contributordoi
Monitoring surgical nociception using multisensor physiological models.
2024cited by 1position: contributordoi
Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis
The Lancet Oncology 2023cited by 241position: middledoi
Dissecting the immune suppressive human prostate tumor microenvironment via integrated single-cell and spatial transcriptomic analyses
Nature Communications 2023cited by 236position: middledoi
NCCN Guidelines® Insights: Prostate Cancer Early Detection, Version 1.2023
Journal of the National Comprehensive Cancer Network 2023cited by 150position: middledoi
Long-term Outcomes of Chemoradiation for Muscle-invasive Bladder Cancer in Noncystectomy Candidates. Final Results of NRG Oncology RTOG 0524—A Phase 1/2 Trial of Paclitaxel + Trastuzumab with Daily Radiation or Paclitaxel Alone with Daily Irradiation
European Urology Oncology 2023cited by 10position: firstdoi
A transcriptional metastatic signature predicts survival in clear cell renal cell carcinoma
Nature Communications 2022cited by 81position: middledoi
Transperineal multiparametric magnetic resonance imaging-ultrasound fusion–targeted prostate biopsy combined with standard template improves perineural invasion detection
Human Pathology 2021cited by 6position: contributordoi
Multiparametric Magnetic Resonance Imaging-Ultrasound Fusion Biopsy Improves but Does Not Replace Standard Template Biopsy for the Detection of Prostate Cancer
The Journal of Urology 2019cited by 43position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 21 papers (2021–2026)Shenglin Mei · Harvard University18 papers (2022–2025)Chin-Lee Wu · NRG Oncology16 papers (2021–2026) · 14 papers (2025–2025)Ninib Baryawno · Karolinska University Hospital14 papers (2025–2025) · 14 papers (2025–2025) · 14 papers (2025–2025)Shulin Wu · Chongqing University of Posts and Telecommunications14 papers (2025–2025)David B. Sykes · Center for Systems Biology14 papers (2025–2025)Hanyu Zhang · China People's Public Security University14 papers (2025–2025)Yanxin Xu · Massachusetts General Hospital14 papers (2025–2025) · 14 papers (2025–2025)Nathan Elias Jeffries · Massachusetts General Hospital14 papers (2025–2025)Chin‐Lee Wu · Massachusetts General Hospital8 papers (2015–2025)Shulin Wu · Guangxi Medical University5 papers (2019–2025)Howard M. Sandler · Samueli Institute4 papers (2014–2024)Taghreed Hirz · Harvard University4 papers (2022–2025)Philip J. Saylor · Harvard University4 papers (2022–2025)David B. Sykes · University of California, Riverside4 papers (2022–2025)William U. Shipley · Harvard University3 papers (2023–2024)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Pulmonary and Respiratory Medicine · Surgery →